Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.74 |
| ▸ | TP53 | P04637 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | PLA2G4B | P0C869 | 5/20 | 0.69 |
| ▸ | RAB9A | P51151 | 1/20 | 0.66 |
| ▸ | RARB | P10826 | 3/20 | 0.65 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.62 |
| ▸ | RELA | Q04206 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | MGLL | Q99685 | 1/20 | 0.62 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8960632 | 1.00 | MAPT (0.74) | MAPTTP53TSHRPLA2G4BRAB9A | |
| SCHEMBL3051368 | 1.00 | MAPT (0.74) | MAPTTP53TSHRPLA2G4BRAB9A | |
| SCHEMBL302793 | 1.00 | MAPT (0.74) | MAPTTP53TSHRPLA2G4BRAB9A | |
| SCHEMBL3051371 | 1.00 | MAPT (0.74) | MAPTTP53TSHRPLA2G4BRAB9A | |
| SCHEMBL12113908 | 1.00 | MAPT (0.74) | MAPTTP53TSHRPLA2G4BRAB9A | |
| SCHEMBL3052051 | 1.00 | MAPT (0.74) | MAPTTP53TSHRPLA2G4BRAB9A | |
| SCHEMBL302596 | 1.00 | MAPT (0.74) | MAPTTP53TSHRPLA2G4BRAB9A | |
| SCHEMBL7171003 | 1.00 | MAPT (0.74) | MAPTTP53TSHRPLA2G4BRAB9A | |
| SCHEMBL21908583 | 1.00 | MAPT (0.74) | MAPTTP53TSHRPLA2G4BRAB9A | |
| SCHEMBL2622417 | 1.00 | MAPT (0.74) | MAPTTP53TSHRPLA2G4BRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116947765-A | Antitumor prodrug, pharmaceutical composition and application thereof in tumor targeted therapy field | 烟台邦杰生物科技有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-115260107-A | Anti-tumor prodrug, pharmaceutical composition and application in tumor targeted therapy field | 烟台邦杰生物科技有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-115260107-B | Antitumor prodrug, pharmaceutical composition and application thereof in tumor targeted therapy field | 烟台邦杰生物科技有限公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-116947765-A | Antitumor prodrug, pharmaceutical composition and application thereof in tumor targeted therapy field | 烟台邦杰生物科技有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-115260107-A | Anti-tumor prodrug, pharmaceutical composition and application in tumor targeted therapy field | 烟台邦杰生物科技有限公司 | 2022-11-01 | — | — | CN | disclosed |
| US-7671033-B2 | Amphiphilic dendritic dipeptides and their self-assembly into helical pores | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671033-B2 | Amphiphilic dendritic dipeptides and their self-assembly into helical pores | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-03-02 | — | — | US | disclosed |
| WO-2006085974-A2 | AMPHIPHILIC DENDRITIC DIPEPTIDES & THEIR SELF-ASSEMBLY INTO HELICAL PORES | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2006-08-17 | — | — | WO | disclosed |
| US-20060088499-A1 | Amphiphilic dendritic dipeptides & their self-assembly into helical pores | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2006-04-27 | — | — | US | disclosed |
| US-5432189-A | Bis-aryl amide and urea antagonists of platelet activating factor | AMERICAN CYANAMID COMPANY (US) | 1995-07-11 | — | — | US | disclosed |
| US-5350759-A | Bis-aryl urea compounds | WISSNER ALLAN (US) | 1994-09-27 | — | — | US | disclosed |
| US-5328921-A | Antagonist of platelet activating factor | AMERICAN CYANAMID COMPANY (US) | 1994-07-12 | — | — | US | disclosed |
| US-5231182-A | Platelet activating factor inhibitor | AMERICAN CYANAMID COMPANY (US) | 1993-07-27 | — | — | US | disclosed |
| US-5225425-A | Respiratory system disorders | AMERICAN CYANAMID COMPANY (US) | 1993-07-06 | — | — | US | disclosed |
| US-5208247-A | Antianaphylactic agents or septic shock | AMERICAN CYANAMID COMPANY (US) | 1993-05-04 | — | — | US | disclosed |
| EP-0530444-A1 | Aryl, amide, imide, and carbamate pyridine antagonists of platelet activating factor | AMERICAN CYANAMID COMPANY (US) | 1993-03-10 | — | — | EP | disclosed |
| US-5128351-A | BIS-ARYL AMIDE AND UREA ANTAGONISTS OF PLATELET ACTIVATING FACTOR | AMERICAN CYANAMID COMPANY (US) | 1992-07-07 | — | — | US | disclosed |
| EP-0458037-A1 | Bis-aryl amide and urea antagonists of platelet activating factor | AMERICAN CYANAMID COMPANY (US) | 1991-11-27 | — | — | EP | disclosed |
| US-4668705-A | Sebosuppressive preparations containing alkoxyaryl alkanols | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1987-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060088499-A1 | Amphiphilic dendritic dipeptides & their self-assembly into helical pores | DNPEP, VIP, APLNR | MAPT 1400/4885TP53 809/4885TSHR 3821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.